Gynae BT 2017
Survival after relapse in PORTEC-1
By site of relapse
By treatment arm
PORTEC Post relapse survival Treatment arm
PORTEC Post relapse survival - no RT arm First failure LRMD
100
100
36 10 10 9 12 9 N F
Vaginal
Pelvic
Meta
Logrank P<.001
75
75
Vaginal
no RT
50
50
25
25
Meta Cumulative percentage
RT 38 34 no RT 58 28 N F
Pelvic
RT
Logrank P<.001
0
0
0
2
4
6
8
years
10
0
2
4
6
8
years
10
At risk:
RT 38
12 32
5
2
1 5
1 1
no RT 58
25
10
r 2004 - 10:13:55
29 Apr 2004 - 10:13:55
➢ Vaginal brachytherapy?
Creutzberg et al, Gynecol Oncol 2003
Made with FlippingBook - Online catalogs